LANTHEUS HOLDINGS, INC.

(LNTH)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur LANTHEUS HOLDINGS, INC.
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 2000 Growth-Defensive Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 3000E Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell Microcap Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 2000 Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell Small Cap Comp Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 2000 Defensive Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 2500 Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell Microcap Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 3000E Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 3000E Growth Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 3000 Value Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell Microcap Growth Index
24/06LANTHEUS HOLDINGS, INC.(NASDAQGM : LNTH) dropped from Russell 2000 Value-Defensive Index
15/06Lantheus Names Paul Blanchfield as Chief Operating Officer
15/06LANTHEUS : Announces Promotion of Paul Blanchfield to Chief Operating Officer - Form 8-K
15/06LANTHEUS HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements ..
15/06Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
15/06Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
15/06Lantheus Holdings, Inc. Announces Executive Changes
13/06Lantheus Holdings, Inc Highlights Preliminary Study Results Demonstrating Potential of ..
13/06Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
13/06Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
13/06Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
13/06Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
13/06Lantheus’ PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistenc..
02/06Lantheus to Present at the Jefferies Healthcare Conference
26/05Lantheus Announces Presentations Featuring PYLARIFY® (Piflufolastat F18), PYLARIFY AI&t..
24/05TRANSCRIPT : Lantheus Holdings, Inc. Presents at UBS Global Healthcare Conference, May-24-..
17/05INSIDER SELL : Lantheus Holdings
17/05TRANSCRIPT : Lantheus Holdings, Inc. - Analyst/Investor Day
17/05LANTHEUS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
16/05Lantheus Hosts Inaugural Investor Day
16/05Lantheus Hosts Inaugural Investor Day
16/05Lantheus Holdings, Inc. Presents Results from a PYLARIFY AI™ Study at the American..
16/05Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological As..
13/05SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
13/05Lantheus Holdings Starts Dosing Patients in Phase 2 Trial to Asses PD-L1 Expression in ..
13/05Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
13/05Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
13/05Lantheus Holdings, Inc. Announces First Patient Dosed in Phase 2 Clinical Trial of NM-0..
11/05INSIDER SELL : Lantheus Holdings
11/05Lantheus Says Medical Organizations Update Guidelines for PET Imaging Agents
11/05Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Can..
11/05Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Can..
10/05Lantheus to Present at the UBS Global Healthcare Conference
10/05Lantheus to Present at the UBS Global Healthcare Conference
09/05Lantheus' Shares Drop Amid Lower Trading Volume Despite B. Riley Beginning Coverage at ..
02/05LANTHEUS HOLDINGS, INC. : Change in Directors or Principal Officers, Submission of Matters..
02/05Declaration of Voting Results by Lantheus Holdings
29/04SECTOR UPDATE : Health Care Stocks Mixed Premarket Friday
29/04SECTOR UPDATE : Health Care
29/04Lantheus Posts Higher Q1 Adjusted Earnings, Revenue; Raises Full-Year Outlook; Shares J..
29/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q1 EPS $0.97
29/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q1 Revenue $208.9M
29/04GUIDANCE : (LNTH) LANTHEUS HOLDINGS Expects Fiscal Year 2022 EPS Range $2.90 - $3.15
29/04LANTHEUS : Reports First Quarter 2022 Financial Results - Form 8-K
29/04TRANSCRIPT : Lantheus Holdings, Inc., Q1 2022 Earnings Call, Apr 29, 2022
29/04LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
29/04Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
29/04LANTHEUS HOLDINGS : Q1 Earnings Snapshot
29/04Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results
29/04Lantheus Holdings, Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 202..
29/04Lantheus Holdings, Inc. Revises Earnings Guidance for the Full Year of Fiscal 2022
15/04LANTHEUS HOLDINGS TO HOST FIRST QUAR : 00 a.m. Eastern Time
04/04Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer
04/04Lantheus Holdings, Inc. Appoints Jean-Claude Provost as Interim Chief Medical Officer
01/04INSIDER SELL : Lantheus Holdings
29/03Lantheus Holdings Signs Deal With Novartis to Include Pylarify in Prostate Cancer Trial..
29/03Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
18/03Lantheus Holdings, Inc Receives a Shareholders Proposal from James McRitchie
15/03TRANSCRIPT : Lantheus Holdings, Inc. Presents at Barclays Global Healthcare Conference 202..
09/03INSIDER SELL : Lantheus Holdings
09/03INSIDER SELL : Lantheus Holdings
08/03Lantheus Holdings to Present at the Barclays Global Healthcare Conference
08/03INSIDER SELL : Lantheus Holdings
1  2  3  4  5  6  7  8Suiv.
Prochain événement sur LANTHEUS HOLDINGS, INC.